13F HOLDINGS REPORT
SECTOR GAMMA AS
Quarter ended Q2 2024 · Filed August 9, 2024 · Accession 0000945621-24-000640
Total Value
$267.7M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 420,163 | $28.8M | 10.77% |
| 2 | PFIZER INC | PFE | 895,000 | $25.0M | 9.36% |
| 3 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 535,000 | $22.2M | 8.30% |
| 4 | MEDTRONIC PLC | MDT | 264,890 | $20.8M | 7.79% |
| 5 | ELEVANCE HEALTH INC | ELV | 24,279 | $13.2M | 4.91% |
| 6 | CVS HEALTH CORP | CVS | 220,000 | $13.0M | 4.85% |
| 7 | INCYTE CORP | INCY | 203,376 | $12.3M | 4.61% |
| 8 | CARDINAL HEALTH INC | CAH | 107,098 | $10.5M | 3.93% |
| 9 | BIOGEN INC | BIIB | 43,985 | $10.2M | 3.81% |
| 10 | AMGEN INC | AMGN | 30,000 | $9.4M | 3.50% |
| 11 | ZIMMER BIOMET HOLDINGS INC | ZBH | 85,000 | $9.2M | 3.45% |
| 12 | BAXTER INTL INC | 071813109 | 260,000 | $8.7M | 3.25% |
| 13 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 104,000 | $8.1M | 3.03% |
| 14 | IONIS PHARMACEUTICALS INC | IONS | 170,000 | $8.1M | 3.03% |
| 15 | BRUKER CORP | BRKRP | 115,472 | $7.4M | 2.75% |
| 16 | ABBOTT LABS | ABLZF | 70,000 | $7.3M | 2.72% |
| 17 | TENET HEALTHCARE CORP | THC | 52,861 | $7.0M | 2.63% |
| 18 | UNIVERSAL HLTH SVCS INC | 913903100 | 35,000 | $6.5M | 2.42% |
| 19 | EDWARDS LIFESCIENCES CORP | EW | 69,153 | $6.4M | 2.39% |
| 20 | AGIOS PHARMACEUTICALS INC | AGIO | 121,844 | $5.3M | 1.96% |
| 21 | BIOMARIN PHARMACEUTICAL INC | BMRN | 63,348 | $5.2M | 1.95% |
| 22 | ALKERMES PLC | ALKS | 194,000 | $4.7M | 1.75% |
| 23 | BIO RAD LABS INC | 090572207 | 16,829 | $4.6M | 1.72% |
| 24 | ALNYLAM PHARMACEUTICALS INC | ALNY | 15,240 | $3.7M | 1.38% |
| 25 | QIAGEN NV | QGEN | 83,484 | $3.4M | 1.28% |
| 26 | CENTENE CORP DEL | CNC | 45,000 | $3.0M | 1.11% |
| 27 | LANTHEUS HLDGS INC | LNTH | 31,712 | $2.5M | 0.95% |
| 28 | VIATRIS INC | VTRS | 103,106 | $1.1M | 0.41% |